On May 21st, 2019, the RSNN organized an ‘Expert Meeting’ on the topic of pharmaceutical compounding. As in many countries, there is a lively debate in the...
Read more
Publication
27 August 2019
Future of the drug label: Perspectives from a multistakeholder dialogue
Recently, the British Journal of Clinical Pharmacology published a paper by members of the RSNN on the future of the drug label. The paper is based on the 3...
Read more
Report
25 July 2019
RSNN Annual Report 2018 - Public Summary
2018 has been a year of expansion and consolidation for the RSNN. The number of RSNN members and partner organization has grown, as well as the number of...
Read more
25 July 2019
Call for Regulatory Science abstracts @ FIGON Dutch Medicines Days 2019
RSNN responds to EMA’s draft strategy ‘Regulatory Science to 2025’
The RSNN is very excited about the draft strategy and foresees significant contributions to innovating and improving regulatory science.
Read more
Newsletter
16 July 2019
RSNN Newsletter 7: July 2019
In the seventh edition, we look at events and publications in 2019. Scroll down for regulatory science news, reports and upcoming events. We share insights...
Read more
Report
15 July 2019
Innovating clinical trials: a rich menu of options in which early dialogue will identify acceptable and feasible approaches
RSNN – Workshop 2019 – Key Takeaways
Read more
Publication
16 May 2019
Regulation is too important to leave it to the regulators
Last month, professor Bert Leufkens published an editorial in the British Journal of Clinical Pharmacology.